ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,380Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 1278

$651K Total Retail Price of All Prescriptions

Rank: 58 out of 1278

1,319 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 1,319 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 1,319 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 12,150 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 784 691 1 2
LISINOPRIL 625 538 2 1
SIMVASTATIN 560 496 3 3
OMEPRAZOLE 516 407 4 6
ATENOLOL 372 345 5 11
HYDROCODONE-ACETAMINOPHEN 371 282 S3 6 7
METFORMIN HCL 365 293 7 4
AMLODIPINE BESYLATE 324 294 8 5
HYDROCHLOROTHIAZIDE 313 265 9 8
CEPHALEXIN 294 245 10 73
GLIPIZIDE 291 265 11 35
CIPROFLOXACIN HCL 289 244 12 53
ZOLPIDEM TARTRATE 282 229 13 16
GABAPENTIN 255 231 14 12
WARFARIN SODIUM 245 221 15 17
FLUTICASONE PROPIONATE 229 177 16 24
METOPROLOL TARTRATE 222 183 17 9
PRAVASTATIN SODIUM 219 203 18 14
METOPROLOL SUCCINATE 211 198 19 23
OXYCODONE-ACETAMINOPHEN 196 140 S2 20 29
FUROSEMIDE 177 148 21 10
LOSARTAN POTASSIUM 169 163 22 19
PANTOPRAZOLE SODIUM 166 134 23 34
ALENDRONATE SODIUM 164 140 24 18
LOVASTATIN 161 129 25 13
POTASSIUM CHLORIDE 148 108 26 21
FLUOXETINE HCL 137 109 27 41
TRAMADOL HCL 132 111 28 25
PROAIR HFA 131 96 29 26
NIFEDIAC CC 129 117 30 135
ENALAPRIL MALEATE 124 120 31 58
CITALOPRAM HBR 117 70 32 22
SERTRALINE HCL 116 88 33 28
TRIAMTERENE-HCTZ 115 95 34 43
TRAZODONE HCL 110 79 35 38
AZITHROMYCIN 109 92 36 37
ADVAIR DISKUS 100 83 37 49
PAROXETINE HCL 98 86 38 56
LANTUS 88 71 39 33
CLOPIDOGREL 88 78 39 45
GEMFIBROZIL 88 71 39 54
CYCLOBENZAPRINE HCL 87 56 R 42 62
DIGOXIN 83 83 43 79
ALLOPURINOL 82 69 44 36
DOXYCYCLINE HYCLATE 81 65 45 123
CLONIDINE HCL 80 78 46 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 75 47 30
PLAVIX 74 68 48 64
LANTUS SOLOSTAR 74 74 48 138
INSULIN SYRINGE 72 57 50 50
DONEPEZIL HCL 71 71 51 48
CARVEDILOL 70 67 52 39
HYDRALAZINE HCL 68 68 53 108
RANITIDINE HCL 66 60 54 20
GLIPIZIDE XL 65 56 55 101
DIOVAN 65 57 55 44
ENDOCET 64 51 S2 57 122
DOXAZOSIN MESYLATE 64 52 57 69
JANUVIA 63 55 59 68
ISOSORBIDE MONONITRATE ER 63 51 59 96
LEVOFLOXACIN 63 50 59 139
CRESTOR 63 59 59 31
LYRICA 62 41 63 104
METHYLPREDNISOLONE 61 51 64 93
MUPIROCIN 56 48 65 197
SPIRIVA 56 54 65 65
OXYBUTYNIN CHLORIDE ER 56 48 65 172
ATORVASTATIN CALCIUM 54 44 68 15
ROPINIROLE HCL 53 41 69 127
ESTRADIOL 53 45 R 69 71
NYSTATIN-TRIAMCINOLONE 50 44 71 179
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.